Related Experiment Video
Updated: Feb 7, 2026
07:45
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
54.7K
Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction.
Stefano Toldo1,2, Dana Austin3, Adolfo G Mauro1,2
1Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.
JACC. Basic to Translational Science
|August 1, 2018
Summary
A novel peptide, SP16, activates the low-density lipoprotein receptor-related protein-1 (LRP1), significantly reducing heart attack size and preserving cardiac function in experimental models.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Background:
- Low-density lipoprotein receptor-related protein-1 (LRP1) is a key membrane receptor involved in cellular signaling.
- LRP1 mediates anti-inflammatory and prosurvival pathways crucial for tissue repair.
Purpose of the Study:
- To investigate the potential of activating LRP1 with a novel small peptide (SP16) for cardioprotection.
- To evaluate the efficacy of SP16 in reducing infarct size and preserving cardiac function during acute myocardial infarction.
Main Methods:
- Synthesis of a small peptide (SP16) based on LRP1 receptor binding site structure-activity.
- Administration of SP16 within 30 minutes of reperfusion in an experimental acute myocardial infarction model.
- Assessment of infarct size and left ventricular systolic function post-treatment.
- Evaluation of SP16's effects using an LRP1 blocking antibody.
Main Results:
- SP16 treatment resulted in a significant reduction of infarct size by over 50% (p < 0.001).
- SP16 preserved left ventricular systolic function (p < 0.001).
- The cardioprotective effects of SP16 were abolished by an LRP1 blocking antibody, confirming the mechanism of action.
Conclusions:
- LRP1 activation by SP16 confers significant cardioprotection during acute myocardial infarction.
- SP16 represents a promising therapeutic agent for limiting myocardial damage and improving cardiac function post-ischemia.
- Targeting LRP1 with small peptides offers a novel strategy for treating cardiovascular diseases.
Keywords:
A2MG, alpha-2 macroglobulinAAT, alpha-1 antitrypsinAMI, acute myocardial infarctionATIII, antithrombin IIIHRP, horseradish peroxidaseIL, interleukinIV, intravenousLPS, lipopolysaccharideLRP1, low-density lipoprotein receptor–related protein-1LV, left ventricularLVFS, left ventricular fractional shorteningPBS, phosphate-buffered salineSEC, serine protease inhibitor–enzyme complexSERPIN, serine protease inhibitorSERPINsTBS, tris-buffered salineTUNEL, terminal deoxynucleotidyl transferase dUTP nick end labelingischemia reperfusionlow-density lipoprotein receptor-related protein-1serine protease inhibitor
Related Concept Videos
01:21G-protein Coupled Receptors
132.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.1K
01:39Receptor-mediated Endocytosis
111.0K
Overview
111.0K
01:15G Protein-coupled Receptors
17.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
17.1K
01:31Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
627
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
627
01:30Transducer Mechanism: G Protein–Coupled Receptors
4.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.2K